Complete and incomplete Kawasaki disease: Clinical differences and coronary artery outcome from a national

S Bressieux-Degueldre1, E Gradoux2, S Di Bernardo1

  • 1Pediatric Cardiology Unit, Department of Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.

Insights

Kawasaki disease (KD) in children presents differently based on completeness, but coronary artery outcomes are similar. Corticosteroids may prevent aneurysms, though regression is slower in incomplete KD cases.

Area of Science:

  • Pediatrics
  • Cardiology
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) is a critical pediatric illness affecting coronary arteries.
  • Distinguishing between complete and incomplete KD is essential for management and prognosis.
  • Coronary artery abnormalities are a major concern in KD patients.

Purpose of the Study:

  • To compare clinical presentation, laboratory findings, treatment, and coronary artery outcomes in children with complete versus incomplete Kawasaki disease.
  • To evaluate the long-term effects of KD on coronary arteries in different disease classifications.
  • To assess the role of specific treatments, like corticosteroids, in managing KD complications.

Main Methods:

  • A prospective surveillance study involving 351 children diagnosed with KD in Switzerland between March 2013 and February 2019.
  • Collection of clinical data, laboratory values, treatment details, and echocardiographic features at diagnosis and 1-year follow-up.
  • Comparative analysis of data between children with complete KD and incomplete KD.

Main Results:

  • Incomplete KD patients were younger and had longer fever duration, but similar C-reactive protein levels compared to complete KD.
  • Corticosteroid treatment was more frequent in incomplete KD patients (p=0.01).
  • Coronary artery involvement (dilation or aneurysm) was observed in 16.2% at diagnosis and 5.8% at follow-up, with no significant difference between groups initially, but a slight increase in aneurysms at follow-up for incomplete KD (p=0.039).

Conclusions:

  • Clinical presentation differs between complete and incomplete Kawasaki disease, but coronary artery outcomes are comparable at diagnosis.
  • Corticosteroid use may be protective against coronary artery aneurysm development.
  • Incomplete KD patients may have a lower rate of coronary artery aneurysm regression, warranting further investigation.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
40
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
19
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
18